Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
Clinical trial NCT05611216 · COMPLETED
Trial details
- NCT number
- NCT05611216
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-12-23
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.